The company continues to report zero revenue and zero gross profit, while administrative expenses surged to $2.2 million in 2026Q1, signaling mounting pressure on the firm's limited resources.
| Net Interest Income | 10.77M | 10.77M | 4.68M |
| NII Growth % | 65.55% | 130.43% | - |
| Net Interest Margin % | 3.95% | 3.99% | 1.8% |
| Interest Income | 10.77M | 10.77M | 4.68M |
| Interest Expense | 0 | 0 | 0 |
| Loan Loss Provision | 0 | 0 | 0 |
| Non-Interest Income | -10.77M | -10.77M | -4.68M |
| Non-Interest Income % | - | - | - |
| Total Revenue | 0 | 0 | 0 |
| Revenue Growth % | 0% | - | - |
| Non-Interest Expense | 3.71M | 1.79M | 702.96K |
| Efficiency Ratio | - | - | - |
| Operating Income | -3.71M | -1.79M | -702.96K |
| Operating Margin % | - | - | - |
| Operating Income Growth % | - | -153.96% | - |
| Pretax Income | 6.74M | 8.99M | 4.14M |
| Pretax Margin % | - | - | - |
| Income Tax | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% |
| Net Income | 6.74M | 8.99M | 4.14M |
| Net Margin % | - | - | - |
| Net Income Growth % | 1.66% | 117.06% | - |
| Net Income (Continuing) | 6.74M | 8.99M | 4.14M |
| EPS (Diluted) | 0.34 | 0.36 | 0.24 |
| EPS Growth % | -56.48% | 50% | - |
| EPS (Basic) | - | 0.36 | 0.26 |
| Diluted Shares Outstanding | 19.98M | 25.3M | 9.82M |
Liquidation and execution risk
As indicated by the most recent quarterly financial statements, VACHU's SG&A expenses surged to $2.2 million in 2026Q1, representing a significant departure from the sub-$500k quarterly run rate observed throughout 2024 and early 2025, signaling potential pressure on the firm's limited operating liquidity.
The sharp increase in administrative costs suggests that the company is likely incurring substantial professional and legal fees associated with late-stage due diligence or potential deal-related negotiations. Investors should monitor whether this spending trajectory is sustainable given the reported cash balance, as it may necessitate further sponsor-led capital injections to maintain operations.
Based on the provided income statement data, VACHU's net income figures, such as the $180.5K reported in 2026Q1, appear disconnected from operational reality, likely reflecting non-cash adjustments related to warrant liabilities rather than any underlying business profitability or revenue-generating activity.
The volatility in net income, which swung from a $2.9 million gain in 2024Q4 to a $180.5K gain in 2026Q1, highlights the accounting complexities inherent in SPAC structures. Analysts should treat these bottom-line figures with caution, as they do not represent operational health and may obscure the actual cash burn occurring within the entity.
According to historical financial filings, VACHU has consistently reported zero revenue and zero gross profit, confirming that the entity lacks any operational leverage as it remains a pre-combination shell vehicle focused exclusively on identifying a target within the healthcare sector.
The absence of revenue means that every dollar of SG&A expense directly erodes the company's net asset value. Without a successful business combination, the firm's cost structure remains purely additive, providing no mechanism for scaling or operational efficiency until a target is integrated.
As reported in recent financial disclosures, the company's operating cash position of $182,103 appears insufficient to support prolonged search activities, raising concerns that VACHU may face significant hurdles in securing the necessary PIPE financing to complete a meaningful healthcare acquisition.
The combination of rising administrative costs and a thin cash runway suggests that the firm's ability to close a deal is highly sensitive to external market conditions. If the sponsors are unable to secure additional funding, the risk of liquidation or a dilutive financing event appears to increase significantly for current shareholders.
Quick answers to the most common questions about buying VACHU stock.
Voyager Acquisition Corp Unit (VACHU) is profitable, generating $9.0M in net income for the fiscal year ending 2025.